If you're having trouble viewing this email, see it on the Web.
Technet21

Home | Invite Others | Digest Archives  
Posts:

technet21 postspacerIntradermal Influenza Vaccination Superior Than IM

technet21 postspacerInternational Neonatal Maternal Immunization Symposium (INMIS)

technet21 postspacerNew Vaccines Could Substantially Reduce TB Incidence and Mortality
Issue 23, 5 October 2009
 
Editorial Note

Two posts from Omesh Bharti, one on new TB vaccines and the other in response to Julian Hickling’s comment that we need to test through clinical trials whether or not we can reduce the number of doses of H1N1 vaccines by using the ID route.

Ener Cagri shares the list of speakers at the International Neonatal Maternal Immunization Symposium to be held in Turkey in March 2010.


by Julian Hickling

You raise a very interesting point about the potential to increase the availability of H1N1 vaccines by delivering a reduced dose by the intradermal (ID) route. Certainly, any approaches that could improve access to H1N1 vaccines would be extremely valuable. However, whether or not dose-sparing is going to be possible with H1N1 vaccines by using the ID route still needs to be tested in clinical trials.

Unfortunately, a review of the literature shows that ID delivery does not always result in the same degree of dose-sparing for all vaccines.

[Read more]

Comment on this post by email or on the web

by Ener Cagri Dinleyici

Here are the speakers of INMIS 2010, which will be held in Antalya, Turkey from March 26 to 28.

     •   Arnaud Marchant (Belgium)
     •   Elke Leuridan (Belgium)
     •   Emre Alhan (Turkey)
     •   Esin Senol (Turkey)

[Read more]

Comment on this post by email or on the web

by Omesh Bharti

Modelling study results based on TB rates in the South-East Asia region and published in the Proceedings of the National Academy of Sciences concluded that new TB vaccines—especially in conjunction with new drugs and diagnostics—could lead to a “substantial reduction” in TB rates and mortality compared with current approaches.

[Read more]

Comment on this post by email or on the web
Photo Courtesy: Ranjit Dhiman
Photo Courtesy: PATH

 

  Web Highlights:
  technet21 post WHO/KFDA workshop on stability evaluation of vaccines
  technet21 post More than four million HIV-positive people now receiving life-saving treatment
  technet21 post Vaccines 2009: world market analysis

 

Register

If you have contributions to make or thoughts to share with others on TechNet21, you can write to the moderator or post directly on the web forums. Click here to change your subscription settings or unsubscribe from the mailing list.

TechNet21 is generously supported by the Bill and Melinda Gates Foundation, under the oversight of WHO and UNICEF. The information in this forum is provided by users, as a service. All contributions are reviewed prior to posting, and all postings are attributed to the authors. The details given in emails will not be voluntarily shared or sold to any outside company and will only be used for verification and to identify postings, if necessary. The authors are solely responsible for their submissions, and the readers are solely responsible for the interpretation of these submissions. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to this forum.

For posts where the author is a WHO staff member, the author alone is reponsible for the views expressed and they do not necessarily represent the decisions, guidelines, recommendations or policies of WHO.